BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 26, 2015
View Archived Issues
Studies support switching to infliximab biosimilar for Crohn's disease and ulcerative colitis
Read More
Ferring Pharmaceuticals acquires drug delivery technology from CTCBIO
Read More
PaQ device improves glycemia control in patients with diabetes
Read More
InSys in-licenses novel therapy for chronic pelvic pain syndrome
Read More
CymaBay reports phase IIb results for arhalofenate in gout
Read More
Pfizer releases results from phase II trial of Trumenba administered with other vaccines in children
Read More
Endpoints met in Teva's phase IIb study of TEV-48125 for prevention of chronic migraine
Read More
Novel TNKS1/2 inhibitor shows potential for in vivo inhibition of Wnt pathway
Read More
Phase III SUMMIT-07 study of NKTR-181 begins in patients with chronic low back pain
Read More
MicuRx begins U.S. phase II trial of MRX-I
Read More
Bristol-Myers Squibb to acquire Flexus Biosciences
Read More
Favipiravir evaluated in phase II Ebola virus disease trial
Read More
N30 Pharmaceuticals changes name to Nivalis Therapeutics
Read More
First launch of Takecab in Japan
Read More
Regen BioPharma updates development progress of dCellVax
Read More
FDA approves Avycaz for cIAI and cUTI
Read More
Fujian Haixi Pharmaceuticals patent reports development of BTK inhibitors
Read More
Takeda describes FFA1 receptor agonists for diabetes
Read More
Roche patents compounds for treatment of RSV
Read More
Wee1-like protein kinase inhibitors prepared and tested at Almac Discovery
Read More
Merck & Co. synthesizes new orexin OX2 receptor antagonists
Read More
NICE issues final guidance on biologic therapies for ulcerative colitis
Read More
Medicago awarded Ebola antibody contract by BARDA
Read More
Shionogi starts phase III trial of peptide vaccine S-588410 for esophageal cancer
Read More
EMA awards orphan drug designation to alvocidib for AML
Read More
NGM and Merck & Co. to discover, develop and commercialize novel biologic therapeutics
Read More
